All In MedTech

Device Trial Radar · NCT07696572

EUS Procedures Using RIVOS™ EUS Access Device

Registry of Patients Undergoing Endoscopic Ultrasound (EUS) Procedures Using the RIVOS™ EUS Access Device

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jul 13, 2026

Primary completion

Jul 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Orlando Health, Inc.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 10, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.

Conditions

  • Pancreatic Fluid Collections
  • Biliary Obstruction
  • Pancreatic Duct Obstruction
  • Chronic Pancreatitis
  • Pancreatic Cancer Non-resectable

Interventions

  • EUS-guided intervention using the RIVOS™ EUS access deviceDevice

    EUS-guided intervention using the RIVOS™ EUS access device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical successTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Orlando Health Digestive Health Institute

    Orlando, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.